| Fri, Dec 18, 2009 | | • | MDCO Recalls Cleviprex Lots
Zacks.com (Fri, Dec 18)
| | Wed, Dec 16, 2009 | | • | Cubist's acquisition to add value
Zacks.com (Wed, Dec 16)
| | Mon, Dec 14, 2009 | | • | Weekly Sentiment Leaders: Nuance, Colgate and Teva
at Seeking Alpha (Mon, Dec 14)
| | • | China Biotech Week in Review: Deals and CRO News
at Seeking Alpha (Mon, Dec 14)
| | Fri, Dec 11, 2009 | | • | Cephalon Sues Actavis
Zacks.com (Fri, Dec 11)
| | Thu, Dec 10, 2009 | | • | Positive Data on Genzyme's Campath
Zacks.com (Thu, Dec 10)
| | Wed, Dec 9, 2009 | | • | Teva Seeks FDA Approval for XM02
Zacks.com (Wed, Dec 9)
| | Mon, Dec 7, 2009 | | • | Monday Options Update: CAG, NYB, RMBS & TEVA
at Seeking Alpha (Mon, Dec 7)
| | Sun, Dec 6, 2009 | | • | Playing Dr. Reddy's Meteoric Rise
at Seeking Alpha (Sun, Dec 6)
| | Fri, Dec 4, 2009 | | • | Cephalon Sues Teva
Zacks.com (Fri, Dec 4)
| | Thu, Dec 3, 2009 | | • | ABT Settles TriCor Dispute with Teva
Zacks.com (Thu, Dec 3)
| | Wed, Dec 2, 2009 | | • | Orphan Drug Status for BioMarin Drug
Zacks.com (Wed, Dec 2)
| | Tue, Dec 1, 2009 | | • | Hedge Funds Warm to Big and Boring
at Barrons.com (Tue, Dec 1)
| | • | How a Decades-Old Drug Is Still a Patented Blockbuster
at The Wall Street Journal Online (Tue, Dec 1)
| | Fri, Nov 27, 2009 | | • | Sanofi Beats on Higher Revenue
Zacks.com (Fri, Nov 27)
| | Wed, Nov 25, 2009 | | • | Cephalon Settles Barr Challenge
Zacks.com (Wed, Nov 25)
| | Mon, Nov 16, 2009 | | • | Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza
at Seeking Alpha (Mon, Nov 16)
| | Thu, Nov 12, 2009 | | • | What Pfizer, KKR and Goldman (Reportedly) Want: Generics!
at The Wall Street Journal Online (Thu, Nov 12)
| | Mon, Nov 9, 2009 | | • | Bionovo: Challenges Ahead, But Poised to Move Higher
at Seeking Alpha (Mon, Nov 9)
| | Sun, Nov 8, 2009 | | • | Cephalon's Upside and Downside
at Seeking Alpha (Sun, Nov 8)
| | Thu, Nov 5, 2009 | | • | A 130 / 30 Global Pharma Strategy
at Seeking Alpha (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | Teva Reports Strong Quarter
Zacks.com (Wed, Nov 4)
|
Add TEVA Blogs to My Yahoo!:
 
| | |
0.49% Nasdaq 0.00%
Financial Blogs
